• Search

Search in Site

Industry news and analysis across pharma and medical devices PharmaDeviceNews.com

  • Home
  • Pharma & Biotech
  • Medical Devices & Diagnostics
  • Features & Analysis
  • Privacy Policy
  • About PharmaDeviceNews
  • Editorial Policy
  • Disclaimer
  • Contact Us
Home»Posts tagged with»diagnostic imaging

Premier Radiology Services deepens outpatient teleradiology push with Global Imaging Solutions

By Pallavi Madhiraju on April 2, 2026   Medical Devices & Diagnostics  

Premier Radiology Services deepens outpatient teleradiology push with Global Imaging Solutions

Premier Radiology Services has acquired Global Imaging Solutions. Read what the teleradiology deal changes for outpatient imaging and market competition.

Photonova Spectra FDA clearance gives GE HealthCare a stronger hand in advanced CT imaging

By Pallavi Madhiraju on March 24, 2026   Medical Devices & Diagnostics  

Photonova Spectra FDA clearance gives GE HealthCare a stronger hand in advanced CT imaging

GE HealthCare’s Photonova Spectra just won FDA clearance. Find out what this means for photon-counting CT, imaging workflows, and hospital adoption.

Next-generation SIGNA MRI gains FDA nod, sharpening GE HealthCare’s imaging strategy

By Soujanya Ravi on February 19, 2026   Medical Devices & Diagnostics  

Next-generation SIGNA MRI gains FDA nod, sharpening GE HealthCare’s imaging strategy

GE HealthCare secures FDA clearance for next-generation SIGNA MRI. Explore clinical impact, workflow gains, and market implications.

Why Princeton Radiology is betting on whole-body MRI and breast screening growth

By Pallavi Madhiraju on January 11, 2026   Medical Devices & Diagnostics  

Why Princeton Radiology is betting on whole-body MRI and breast screening growth

Princeton Radiology acquires two centers from RAI—see how this move reshapes outpatient imaging strategy, tech, and patient services in New Jersey.

Can Positron Corporation’s $2m raise unlock growth in cardiac PET-CT imaging?

By Venkatesh B on January 1, 2026   Medical Devices & Diagnostics  

Can Positron Corporation’s $2m raise unlock growth in cardiac PET-CT imaging?

Positron Corporation raises $2 million to fund PET-CT system expansion in cardiac and oncology imaging. Can it scale fast enough to compete?

Can embedded AI help Philips challenge GE and Siemens in imaging software?

By Pallavi Madhiraju on December 1, 2025   Medical Devices & Diagnostics  

Can embedded AI help Philips challenge GE and Siemens in imaging software?

Philips unveils AVW 16 and new AI integrations at RSNA 2025. Find out how its cloud-native platform strategy could reshape diagnostic imaging workflows.

Philips bets on AI automation to solve cardiac MR access and staffing gaps

By Pallavi Madhiraju on November 26, 2025   Medical Devices & Diagnostics  

Philips bets on AI automation to solve cardiac MR access and staffing gaps

Find out how Philips’ new AI-powered cardiac MR innovations could transform access, speed, and diagnostic precision in cardiovascular imaging.

Recent Posts

  • AACR 2026: SAGA Diagnostics pushes Pathlight MRD deeper into metastatic breast and ovarian cancer
  • Agenus AACR 2026 data show immune reprogramming signal in PD-1 refractory gastroesophageal cancer
  • AACR 2026: Can Zai Lab’s zocilurtatug pelitecan change the treatment picture for small cell lung cancer brain metastases?
  • How JANX014 expands Janux Therapeutics’ tumor-activated platform strategy in prostate cancer immunotherapy
  • What Medicus Pharma Ltd.’s SkinJect application signals for Hedgehog pathway-driven cancers
  • Why Bioxodes’ adaptive trial strategy could accelerate approval timelines in stroke therapeutics
  • What Kura Oncology’s latest data reveals about resistance biology in kidney cancer
  • Can Fate Therapeutics, Inc. solve the conditioning chemotherapy problem in CAR T?
  • Could Ampligen become a late-stage pancreatic cancer breakthrough after AIM ImmunoTech’s latest clinical push?
  • What the new J-code means for Glaukos’ Epioxa launch and the future of keratoconus reimbursement
  • Molgramostim review pushed to November: what Savara’s FDA delay means for autoimmune PAP
  • What SurGenTec’s TiLink navigation clearance means for surgeons using minimally invasive SI joint fusion systems
    • About PharmaDeviceNews
    • Contact Us
    • Disclaimer
    • Editorial Policy
    • Privacy Policy
© 2026, ↑ PharmaDeviceNews
Log in - Powered by WordPress - Gabfire Themes